Search research articles
Contact Us
Filters
Showing results (191-200 of 213) with videos related to
Page
of 22
Sort By:
Journal of Translational Medicine
|
November 18, 2017
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016
Paolo A Ascierto, Sanjiv S Agarwala, Gennaro Ciliberto, et al.
Cell Reports
|
March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
Raul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Cytotherapy
|
January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau, Mauro Krampera, John Barrett, et al.
Nature Medicine
|
November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Journal of Translational Medicine
|
March 29, 2011
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
Paolo A Ascierto, Eleonora De Maio, Stefano Bertuzzi, et al.
Journal of Translational Medicine
|
May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Sara K Silbert, Flavia Gava, Bonnie Yates, et al.
Cell Reports Methods
|
May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells
Naritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 213) with videos related to
Sort By:
Page
of 22
Journal of Translational Medicine
|
November 18, 2017
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016
Paolo A Ascierto, Sanjiv S Agarwala, Gennaro Ciliberto, et al.
Cell Reports
|
March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
Raul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Cytotherapy
|
January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau, Mauro Krampera, John Barrett, et al.
Nature Medicine
|
November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Journal of Translational Medicine
|
March 29, 2011
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
Paolo A Ascierto, Eleonora De Maio, Stefano Bertuzzi, et al.
Journal of Translational Medicine
|
May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Sara K Silbert, Flavia Gava, Bonnie Yates, et al.
Cell Reports Methods
|
May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells
Naritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Page
of 22